Savitz Drug Store to Pay $275,000 to Resolve Alleged Controlled Substance Act Violations
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Savitz Drug Store to Pay $275,000 to Resolve Alleged Controlled Substance Act Violations

Savitz Drug Store to Pay $275,000 to Resolve Alleged Controlled Substance Act Violations

January 06, 2023
|
Share Article
|
Download Press Release
For Immediate Release
Contact: SA Crystal Harper
Phone Number: (571) 362-3433

COLUMBIA, S.C. – Savitz Drug Store, Inc., has agreed to pay $275,000 to resolve allegations that it committed recordkeeping and dispensing violations of the Controlled Substances Act (CSA). These requirements are designed to prevent the diversion of controlled substances.

This civil settlement includes a corrective action plan and is the culmination of a joint investigation by the United States Drug Enforcement Agency (DEA); S.C. Department of Health and Environmental Control, Bureau of Drug Control (DHEC); and U.S. Attorney’s Office that began in March 2022, when a routine controlled substance inspection by S.C. DHEC revealed that Savitz could not account for approximately 22,056 milliliters of Promethazine with Codeine.

“The mission of DEA’s Office of Diversion Control is to prevent, detect and investigate the diversion of controlled pharmaceutical and listed chemicals from legitimate sources,” said Robert J. Murphy, the Special Agent in Charge (SAC) of the Atlanta Division of the DEA. “In this case, DEA Diversion Investigators did an outstanding job of uncovering this pharmacist’s systemic record-keeping violations and failures to safeguard controlled substances.”

“When pharmacists fail to comply with federal law, they can put controlled substances on the street and place the public at great risk,” said U.S. Attorney Adair F. Boroughs. “Our office is committed to working with our partners to hold pharmacists accountable for their responsibilities under federal law.”

The United States alleges that the Pharmacist-in-Charge of Savitz failed to properly safeguard his Controlled Substance Ordering System (CSOS) private user identification login and password, which resulted in a staff Pharmacist using the CSOS login and password to order controlled substances at least one hundred times.

The United States further alleges that due to Savitz’s failure to maintain complete and accurate controlled substance records and necessary oversight, a tenured Pharmacy Technician at Savitz was able to divert 46 bottles of Promethazine with Codeine (Schedule V) from Savitz over a three-month timeframe. Promethazine with Codeine is a cough syrup that can be used as the main ingredient in a drink mixture commonly known as “Lean” or “Purple Drank.” Effects of “Lean” or “Purple Drank” are consistent with the abuse characteristics of other opioids and result in a sedative and woozy or swooning euphoria.

The conduct outlined in the settlement agreement is merely alleged; the agreement does not constitute an admission of liability by Savitz. 

A main objective of the CSA is controlling illegitimate traffic in controlled substances.  To prevent the diversion of controlled substances, the CSA regulates persons, companies, and other entities that manufacture, distribute, and dispense controlled substances. 

This matter was investigated by DHEC Agent Ann Shields, DEA Acting Group Supervisor Derek Barr, DEA Investigator Kelli Capehart, and Assistant U.S. Attorney Johanna Valenzuela of the U.S. Attorney’s Office for the District of South Carolina.

The DEA encourages parents, along with their children, to educate themselves about the dangers of legal and illegal drugs by visiting DEA’s interactive websites at www.JustThinkTwice.com, www.GetSmartAboutDrugs.com, www.CampusDrugPrevention.gov, and www.dea.gov . Also follow DEA Atlanta via Twitter at @DEAATLANTADiv.

 

# # #

 

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Jae W. Chung, Actingx Special Agent in Charge - Atlanta
@DEAAtlantaDiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster